Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2025-07-14 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
关于调整2025年限制性股票激励计划激励对象名单及授予价格的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding adjustments to the 2025 restricted stock incentive plan, including changes to the list of incentive recipients and the grant price. It details board and shareholder meeting approvals, legal opinions, and procedural compliance. The content focuses on changes to stock incentive plans and related governance matters rather than financial results, earnings, or capital raising. It is not a full financial report, earnings release, or capital update. It is also not a proxy solicitation or voting results announcement. The document is a formal announcement of changes to management incentive plans, which falls under regulatory announcements related to management and governance but does not fit the exact category of Remuneration Information (DEF 14A) since it is about stock incentive plan adjustments rather than executive compensation disclosures. Given the nature of the announcement and the lack of financial statements or detailed remuneration data, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-07-14 Chinese
2025年限制性股票激励计划首次授予激励对象名单（授予日）
Regulatory Filings Classification · 95% confidence The document is a public announcement from Huizhou Jin Hao Medical Technology Co., Ltd. regarding the first grant list of restricted stock incentive plan for 2025. It lists the names, positions, and stock quantities granted to directors, senior management, and core employees. The document is relatively short (1939 characters) and focuses on the details of a stock incentive plan grant. It does not contain financial statements, audit information, or detailed financial analysis. It is not a report like an annual or interim report, nor is it a call transcript or legal proceeding. It is an announcement related to share-based compensation and equity incentives. This type of document fits best under the category of Regulatory Filings (RNS), as it is a regulatory announcement about stock incentives and does not fit other more specific categories such as Director's Dealing or Share Issue/Capital Change, since it is about incentive plan grants rather than share transactions or capital changes.
2025-07-14 Chinese
证券事务代表任命公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the appointment of a securities affairs representative at the company. It details the appointment decision made by the board, the qualifications of the appointee, and the compliance with relevant laws. There is no financial data, no report or presentation content, and no mention of voting results or dividends. This fits the category of Board/Management Information (MANG), as it concerns a change in a key company representative role related to securities affairs.
2025-07-14 Chinese
独立董事专门会议关于2025年限制性股票激励计划首次授予相关事项的审查意见
Board/Management Information Classification · 95% confidence The document is a formal announcement from the independent directors' special meeting regarding the review and approval of matters related to the company's 2025 restricted stock incentive plan, including adjustments to the incentive object list and grant price, and the initial grant of restricted stock. It references relevant laws, regulations, and company bylaws, and provides detailed opinions on the legality and compliance of the incentive plan. The document is not a full financial report, earnings release, or regulatory filing but a specific governance-related announcement about stock incentive plans. It does not contain financial statements or earnings data, nor is it a proxy solicitation or voting result announcement. The content fits best under Board/Management Information (MANG) as it relates to management decisions and board-level approvals on stock incentive plans.
2025-07-14 Chinese
2024年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as an "Annual Equity Distribution Implementation Announcement" for the year 2024 by Huizhou Jin Hao Medical Technology Co., Ltd. It details the dividend distribution plan, including the cash dividend amount, tax deductions, record dates, and payment methods. The document is an announcement of the dividend amount and related details to shareholders, not a full financial report or annual report. It specifically focuses on the dividend distribution for the year 2024, with no comprehensive financial statements or management discussion. Therefore, it fits the category of a Notice of Dividend Amount (DIV). The document length is short (2001 characters), consistent with a dividend announcement rather than a full report.
2025-06-30 Chinese
关于持股5%以上股东持股比例被动增加触及5%整数倍的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement from a company regarding a change in shareholding percentage of a shareholder crossing the 5% threshold due to share repurchase and cancellation. It details the passive increase in shareholding percentage of a significant shareholder, Zhejiang Haokun Shengfa Asset Management Co., Ltd., from 4.9999% to 5.0244%. The document includes specific shareholding data before and after the change and states that this change does not affect control or require further filings like acquisition reports. This matches the definition of a Major Shareholding Notification, which involves notifying changes in significant share ownership levels crossing thresholds such as 5%. The document length is short and focused solely on this shareholding change, with no financial statements or other report content. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2025-06-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.